# Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)

> **NCT02273856** · — · TERMINATED · sponsor: **Astellas Pharma International B.V.** · enrollment: 25 (actual)

## Conditions studied

- Indolent Non Hodgkin's Lymphoma (iNHL)
- Chronic Lymphocytic Leukaemia (CLL)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02273856
- **Lead sponsor:** Astellas Pharma International B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** The study was terminated due to insufficient subject enrollment and very slow enrollment.
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02273856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02273856, "Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02273856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*